BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8427321)

  • 1. The effects of intrauterine cocaine exposure in newborns.
    Bateman DA; Ng SK; Hansen CA; Heagarty MC
    Am J Public Health; 1993 Feb; 83(2):190-3. PubMed ID: 8427321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants.
    Weathers WT; Crane MM; Sauvain KJ; Blackhurst DW
    Pediatrics; 1993 Feb; 91(2):350-4. PubMed ID: 8424009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for aboriginal low birthweight, intrauterine growth retardation and preterm birth in the Darwin Health Region.
    Sayers S; Powers J
    Aust N Z J Public Health; 1997 Aug; 21(5):524-30. PubMed ID: 9343899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cohort study of alkaloidal cocaine ("crack") in pregnancy.
    Cherukuri R; Minkoff H; Feldman J; Parekh A; Glass L
    Obstet Gynecol; 1988 Aug; 72(2):147-51. PubMed ID: 3393357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
    Vega J; Sáez G; Smith M; Agurto M; Morris NM
    Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):229-37. PubMed ID: 9445496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between patterns of maternal substance use and infant birth weight, length, and head circumference.
    Shankaran S; Das A; Bauer CR; Bada HS; Lester B; Wright LL; Smeriglio V
    Pediatrics; 2004 Aug; 114(2):e226-34. PubMed ID: 15286261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain growth among fetuses exposed to cocaine in utero: asymmetrical growth retardation.
    Little BB; Snell LM
    Obstet Gynecol; 1991 Mar; 77(3):361-4. PubMed ID: 1992399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse perinatal outcome in parturients who use crack cocaine.
    Sprauve ME; Lindsay MK; Herbert S; Graves W
    Obstet Gynecol; 1997 May; 89(5 Pt 1):674-8. PubMed ID: 9166299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study.
    van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
    Drug Alcohol Depend; 2010 Jun; 109(1-3):243-7. PubMed ID: 20171023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth.
    Salafia CM; Ernst LM; Pezzullo JC; Wolf EJ; Rosenkrantz TS; Vintzileos AM
    Am J Perinatol; 1995 Mar; 12(2):106-10. PubMed ID: 7779189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assisted reproductive technology surveillance--United States, 2011.
    Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Barfield WD;
    MMWR Surveill Summ; 2014 Nov; 63(10):1-28. PubMed ID: 25412164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal patterns of cocaine use in pregnancy. Perinatal outcome.
    Chasnoff IJ; Griffith DR; MacGregor S; Dirkes K; Burns KA
    JAMA; 1989 Mar 24-31; 261(12):1741-4. PubMed ID: 2918671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal complications associated with maternal tobacco use.
    Andres RL; Day MC
    Semin Neonatol; 2000 Aug; 5(3):231-41. PubMed ID: 10956448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response effect of fetal cocaine exposure on newborn neurologic function.
    Chiriboga CA; Brust JC; Bateman D; Hauser WA
    Pediatrics; 1999 Jan; 103(1):79-85. PubMed ID: 9917443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assisted Reproductive Technology Surveillance — United States, 2012.
    Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Warner L; Barfield WD;
    MMWR Surveill Summ; 2015 Aug; 64(6):1-29. PubMed ID: 26270152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine use during pregnancy and intrauterine growth retardation: new insights based on maternal hair tests.
    Kuhn L; Kline J; Ng S; Levin B; Susser M
    Am J Epidemiol; 2000 Jul; 152(2):112-9. PubMed ID: 10909947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth outcomes for infants of drug abusing mothers.
    Kaye K; Elkind L; Goldberg D; Tytun A
    N Y State J Med; 1989 May; 89(5):256-61. PubMed ID: 2733887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripartum cocaine use: estimating risk of adverse pregnancy outcome.
    Cohen HR; Green JR; Crombleholme WR
    Int J Gynaecol Obstet; 1991 May; 35(1):51-4. PubMed ID: 1680076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample.
    Richardson GA; Hamel SC; Goldschmidt L; Day NL
    Pediatrics; 1999 Aug; 104(2):e18. PubMed ID: 10429136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.